Life ScienceCompany
Teva Pharmaceutical Industries M&A Summary
Teva Pharmaceutical Industries has acquired 23 companies. A total of 3 acquisitions came from private equity firms. It has also divested 9 assets.
Teva Pharmaceutical Industries’ largest acquisition to date was in 2015, when it acquired Allergan Generics for $40.5B. It’s largest disclosed sale occurred in 2017, when it sold Teva Pharmaceutical Industries - PARAGARD to CooperSurgical for $1.1B. Teva Pharmaceutical Industries has acquired in 7 different US states, and 8 countries. The Company’s most targeted sectors include life science (87%) and distribution (5%).
Teva Pharmaceutical Industries Business Overview
Where is Teva Pharmaceutical Industries headquartered?
Teva Pharmaceutical Industries is headquartered in Tel Aviv, Israel.
What is Teva Pharmaceutical Industries’ revenue?
Teva Pharmaceutical Industries disclosed revenue of 15,845M USD for 2023 and 14,925M USD for 2022.
How many employees does Teva Pharmaceutical Industries have?
Teva Pharmaceutical Industries has 35,001 employees.
What sector is Teva Pharmaceutical Industries in?
Teva Pharmaceutical Industries is a life science company.
When was Teva Pharmaceutical Industries founded?
Teva Pharmaceutical Industries was founded in 1901.
M&A Summary
-
M&A Total Activity32
- M&A Buy Activity23
- M&A Sell Activity9
- Total Sectors Invested 4
- Total Countries Invested 8
- M&A Buy/Sell Connections 14
- M&A Advisors 12